Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 4 , Pages 261-268 , April 2011

The effect of comprehensive lifestyle intervention or metformin on obesity in young women

  • S.S. Lim

      Affiliations

    • Discipline of Physiology, School of Molecular and Biomedical Science, Adelaide University, SA 5000, Australia
    • CSIRO Human Nutrition, Adelaide, SA 5000, Australia
    • Corresponding Author InformationCorresponding author. CSIRO Human Nutrition, PO Box 10041, Adelaide, SA 5000, Australia.
    • ,
  • R.J. Norman

      Affiliations

    • Discipline of Obstetrics and Gynaecology, Adelaide University, SA 5000, Australia
    • ,
  • P.M. Clifton

      Affiliations

    • CSIRO Human Nutrition, Adelaide, SA 5000, Australia
    • ,
  • M. Noakes

      Affiliations

    • CSIRO Human Nutrition, Adelaide, SA 5000, Australia

Received 13 July 2009 ,Revised 8 October 2009 ,Accepted 14 October 2009.

References 

  1. McTigue KM, Garrett JM, Popkin BM. The natural history of the development of obesity in a cohort of young U.S. adults between 1981 and 1998. Ann Intern Med. 2002;136:857–864
  2. Kuczmarski RJ. Prevalence of overweight and weight gain in the United States. Am J Clin Nutr. 1992;55:495S–502S
  3. Colditz GA, Coakley E. Weight, weight gain, activity, and major illnesses: the Nurses' Health Study. Int J Sports Med. 1997;3(18 Suppl):S70–S162
  4. Fairfield KM, Willett WC, Rosner BA, Manson JE, Speizer FE, Hankinson SE. Obesity, weight gain, and ovarian cancer. Obstet Gynecol. 2002;100:288–296
  5. Franz MJ, VanWormer JJ, Crain AL, Boucher JL, Histon T, Caplan W, et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc. 2007;107:1755–1767
  6. Honas JJ, Early JL, Frederickson DD, O'Brien MS. Predictors of attrition in a large clinic-based weight-loss program. Obes Res. 2003;11:888–894
  7. Salpeter SR, Buckley NS, Kahn JA, Salpeter EE. Meta-analysis: metformin treatment in persons at risk for diabetes mellitus. Am J Med. 2008;121:149–157
  8. Lord JM, Flight IH, Norman RJ. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. Bmj. 2003;327:951–953
  9. Lachin JM, Christophi CA, Edelstein SL, Ehrmann DA, Hamman RF, Kahn SE, et al. Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program. Diabetes. 2007;56:1153–1159
  10. Crandall J, Schade D, Ma Y, Fujimoto WY, Barrett-Connor E, Fowler S, et al. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci. 2006;61:1075–1081
  11. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403
  12. Australian Government DoHaA . Australian Guide to healthy eating. http://www.health.gov.au/internet/wcms/publishing.nsf/Content/health-pubhlth-strateg-food-guide-whatis.htm
  13. Australian Government DoHaA . National physical activity guidelines for adults. http://www.health.gov.au/internet/wcms/publishing.nsf/Content/phd-physical-activity-adults-pdf-cnt.htm
  14. Hill JO, Wyatt HR. Role of physical activity in preventing and treating obesity. J Appl Physiol. 2005;99:765–770
  15. Moran LJ, Noakes M, Clifton PM, Tomlinson L, Galletly C, Norman RJ. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88:812–819
  16. National Institute of Health NH, Lung and Blood Institute. 2002 Third report of the National cholesterol education program (NCEP). Expert Panel Detection Eval Treat High Blood Cholesterol Adults (Adult Treat Panel NIH Publ No. 05–5215).
  17. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–1395
  18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  20. Huber-Buchholz MM, Carey DG, Norman RJ. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab. 1999;84:1470–1474
  21. Mallinckrodt CH, Clark WS, David SR. Accounting for dropout bias using mixed-effects models. J Biopharm Stat. 2001;11:9–21
  22. Stevens J, Truesdale KP, McClain JE, Cai J. The definition of weight maintenance. Int J Obes (Lond). 2006;30:391–399
  23. Wu RR, Zhao JP, Jin H, Shao P, Fang MS, Guo XF, et al. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA. 2008;299:185–193
  24. Welch N, McNaughton SA, Hunter W, Hume C, Crawford D. Is the perception of time pressure a barrier to healthy eating and physical activity among women?. Public Health Nutr. 2008;1–8
  25. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992;56:320–328

☆ This work was supported by CSIRO Human Nutrition, Adelaide, Australia. This trial was registered with the Australian Clinical Trials Registry (ACTRN012607000213448).

PII: S0939-4753(09)00252-X

doi: 10.1016/j.numecd.2009.10.006

Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 4 , Pages 261-268 , April 2011

Article Tools

* Image Usage & Resolution